Savant Mehta to Middle Aged
This is a "connection" page, showing publications Savant Mehta has written about Middle Aged.
Connection Strength
0.040
-
Marya NB, Powers PD, AbiMansour JP, Marcello M, Thiruvengadam NR, Nasser-Ghodsi N, Rau P, Zivny J, Mehta S, Marshall C, Leonor P, Che K, Abu Dayyeh B, Storm AC, Petersen BT, Law R, Martin JA, Vargas EJ, Chandrasekhara V. Multicenter validation of a cholangioscopy artificial intelligence system for the evaluation of biliary tract disease. Endoscopy. 2026 Jan; 58(1):47-55.
Score: 0.018
-
Punzalan CS, Barry C, Zacharias I, Rodrigues J, Mehta S, Bozorgzadeh A, Barnard GF. Sofosbuvir plus simeprevir treatment of recurrent genotype 1 hepatitis C after liver transplant. Clin Transplant. 2015 Dec; 29(12):1105-11.
Score: 0.009
-
Sanyal AJ, Fontana RJ, Di Bisceglie AM, Everhart JE, Doherty MC, Everson GT, Donovan JA, Malet PF, Mehta S, Sheikh MY, Reid AE, Ghany MG, Gretch DR. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointest Endosc. 2006 Dec; 64(6):855-64.
Score: 0.005
-
Fontana RJ, Sanyal AJ, Mehta S, Doherty MC, Neuschwander-Tetri BA, Everson GT, Kahn JA, Malet PF, Sheikh MY, Chung RT, Ghany MG, Gretch DR. Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial. Am J Gastroenterol. 2006 May; 101(5):983-92.
Score: 0.005
-
Bonkovsky HL, Troy N, McNeal K, Banner BF, Sharma A, Obando J, Mehta S, Koff RS, Liu Q, Hsieh CC. Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C. J Hepatol. 2002 Dec; 37(6):848-54.
Score: 0.004